Maravai LifeSciences Holdings, Inc. MRVI 深 滬
已收盤 09-20 16:00:00 美东时间
8.44
-0.400
-4.52%
華盛通- 最 高8.99
- 今 開8.87
- 成交量 375.20万股
- 最 低 8.24
- 昨 收 8.84
- 總市值 11.14亿
- 52周最高 11.555
- 市盈率 靜 --
- 換手率 2.84%
- 52周最低 4.52
- 委 比 -72.14%
- 總股本 1.32亿
- 歷史最高 63.55
- 量 比 2.39
- 振 幅 8.48%
- 歷史最低 4.52
- 每 手 1
- 風險率 1.57%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Repligen financial statements require restatement due to revenue recognition error
Repligen (NASDAQ:RGEN) said it will need to restate some of its financial statements after a review found that the timing of recognition of product revenue from a COVID-related cancellation payment wa...
09-19 04:48
新浪财经ESG：MRVI MSCI（明晟）ESG评级调降至B
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务，助力上市公司传播ESG理念，提升ESG可持续发展表现。点击查看【 ESG评级中...
09-05 07:00
Buy Rating Affirmed: Overlooked Long-Term Benefits of Repligen’s Potential Maravai Acquisition
Analyst Justin Bowers from Deutsche Bank maintained a Buy rating on Repligen (R...
08-20 15:17
美股牛股 | 猴痘概念股强势走强！EBS涨24%；极星汽车大涨逾20%
猴痘概念股强势走强！Emergent BioSolutions涨24%；极星汽车 隔夜涨20.2%，开始在美国工厂生产电动汽车>>
08-17 14:20
Maravai LifeSciences jumps on report of Repligen takeover offer
Maravai LifeSciences (NASDAQ:MRVI) surged 18% after a report that Repligen (NASDAQ:RGEN) approached the company with a takeover offer. Repligen quickly dropped 7.4%. There's no certainty that Maravai ...
08-16 23:45
Pfizer, BioNTech post partial win in late-stage trial for COVID/flu combo shot
Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) announced Friday that a Phase 3 clinical trial for their combined mRNA vaccine against influenza and COVID-19 met only one of its two primary objectives. T...
08-16 19:18
快讯 | maravai lifesciences：摩根士丹利将评级下调至等权级，从超配级。
Maravai LifeSciences : Morgan Stanley Cuts to Equal-Weight From Overweight
08-14 18:54
快讯 | 摩根士丹利将马拉维生命科学公司的评级从增持下调至持平，导致股价预盘下跌2.3%。
Maravai LifeSciences Shares Down 2.3% Premarket After Morgan Stanley Cuts to Eq...
08-13 20:27
Maravai cut at Morgan Stanley; Pfizer/BioNTech headwinds cited
Morgan Stanley downgraded Maravai LifeSciences Holdings (NASDAQ:MRVI) to Equal Weight from Overweight on Tuesday, citing, among other things, a potential impact from headwinds faced by Pfizer (NYSE:PF...
08-13 20:12
Unveiling 4 Analyst Insights On Maravai LifeSciences
During the last three months, 4 analysts shared their evaluations of Maravai Li...
08-13 20:01
